JP2002514649A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002514649A5 JP2002514649A5 JP2000548338A JP2000548338A JP2002514649A5 JP 2002514649 A5 JP2002514649 A5 JP 2002514649A5 JP 2000548338 A JP2000548338 A JP 2000548338A JP 2000548338 A JP2000548338 A JP 2000548338A JP 2002514649 A5 JP2002514649 A5 JP 2002514649A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- alkyl
- compound
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 description 17
- 150000003883 epothilone derivatives Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 125000004434 sulfur atom Chemical group 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000012050 conventional carrier Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical group IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000003898 horticulture Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19820599.6 | 1998-05-08 | ||
| DE19820599A DE19820599A1 (de) | 1998-05-08 | 1998-05-08 | Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung |
| PCT/EP1999/003159 WO1999058534A2 (de) | 1998-05-08 | 1999-05-07 | Epithilonderivate, verfahren zu deren herstellung und deren verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002514649A JP2002514649A (ja) | 2002-05-21 |
| JP2002514649A5 true JP2002514649A5 (https=) | 2006-06-29 |
Family
ID=7867085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548338A Withdrawn JP2002514649A (ja) | 1998-05-08 | 1999-05-07 | エポチロン誘導体、それらの製造方法、並びにそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6982280B1 (https=) |
| EP (1) | EP1077980B1 (https=) |
| JP (1) | JP2002514649A (https=) |
| KR (1) | KR20010052325A (https=) |
| AR (1) | AR018344A1 (https=) |
| AT (1) | ATE234842T1 (https=) |
| AU (1) | AU754212B2 (https=) |
| CA (1) | CA2330812A1 (https=) |
| DE (2) | DE19820599A1 (https=) |
| ES (1) | ES2195577T3 (https=) |
| HU (1) | HUP0102283A3 (https=) |
| IL (1) | IL139480A0 (https=) |
| TW (1) | TW568910B (https=) |
| WO (1) | WO1999058534A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| WO1999001124A1 (en) | 1996-12-03 | 1999-01-14 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| GB9810659D0 (en) | 1998-05-18 | 1998-07-15 | Ciba Geigy Ag | Organic compounds |
| US6518421B1 (en) | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
| SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
| DE10355223A1 (de) * | 2003-11-26 | 2005-06-30 | Institut für Pflanzenbiochemie (IPB) | Neue Makrocyclen zur Behandlung von Krebserkrankungen |
| EP1674098A1 (en) | 2004-12-23 | 2006-06-28 | Schering Aktiengesellschaft | Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water |
| EP2634252B1 (en) | 2005-02-11 | 2018-12-19 | University of Southern California | Method of expressing proteins with disulfide bridges |
| US20110104664A1 (en) | 2006-03-31 | 2011-05-05 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents |
| US8008256B2 (en) * | 2006-05-01 | 2011-08-30 | University Of Southern California | Combination therapy for treatment of cancer |
| EP2065054A1 (en) | 2007-11-29 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Combinations comprising a prostaglandin and uses thereof |
| DE102007059752A1 (de) | 2007-12-10 | 2009-06-18 | Bayer Schering Pharma Aktiengesellschaft | Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone |
| EP2070521A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Surface-modified nanoparticles |
| WO2010056901A2 (en) | 2008-11-13 | 2010-05-20 | University Of Southern California | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
| EP2210584A1 (en) | 2009-01-27 | 2010-07-28 | Bayer Schering Pharma Aktiengesellschaft | Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer |
| AU2011255647A1 (en) | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
| US9764038B2 (en) | 2011-12-23 | 2017-09-19 | Innate Pharma | Enzymatic conjugation of antibodies |
| WO2014009426A2 (en) | 2012-07-13 | 2014-01-16 | Innate Pharma | Screening of conjugated antibodies |
| US10036010B2 (en) | 2012-11-09 | 2018-07-31 | Innate Pharma | Recognition tags for TGase-mediated conjugation |
| EP2968582B1 (en) | 2013-03-15 | 2020-07-01 | Innate Pharma | Solid phase tgase-mediated conjugation of antibodies |
| EP3010547B1 (en) | 2013-06-20 | 2021-04-21 | Innate Pharma | Enzymatic conjugation of polypeptides |
| JP6744212B2 (ja) | 2013-06-21 | 2020-08-19 | イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． | ポリペプチドの酵素的結合 |
| WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| US5351146A (en) * | 1993-03-01 | 1994-09-27 | At&T Bell Laboratories | All-optical network architecture |
| US5781537A (en) * | 1995-07-07 | 1998-07-14 | International Business Machines Corporation | Setting up, taking down and maintaining connections in a communications network |
| DK1186606T4 (da) | 1995-11-17 | 2011-12-05 | Biotechnolog Forschung Gmbh | Epothilonderivater, deres fremstilling og anvendelse |
| DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
| DK1367057T3 (da) | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
| US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| US6304349B1 (en) * | 1998-06-30 | 2001-10-16 | Lucent Technologies Inc. | WDM optical communications networks and methods for provisioning |
| US6445844B1 (en) * | 1999-09-15 | 2002-09-03 | Xros, Inc. | Flexible, modular, compact fiber optic switch |
| US7092633B2 (en) * | 2000-11-14 | 2006-08-15 | University Of Texas System Board Of Regents | System and method for configuring optical circuits |
| US6982951B2 (en) * | 2000-12-21 | 2006-01-03 | At&T Corp. | Method for selecting a restoration path in a mesh network |
| US7212495B2 (en) * | 2001-02-21 | 2007-05-01 | Polytechnic University | Signaling for reserving a communications path |
| AU2002305113A1 (en) * | 2001-03-29 | 2002-10-15 | Atoga Systems, Inc. | Open ring architectures for optical wdm networks |
| US20020194339A1 (en) * | 2001-05-16 | 2002-12-19 | Lin Philip J. | Method and apparatus for allocating working and protection bandwidth in a telecommunications mesh network |
| AU2002351589A1 (en) * | 2001-06-27 | 2003-03-03 | Brilliant Optical Networks | Distributed information management schemes for dynamic allocation and de-allocation of bandwidth |
-
1998
- 1998-05-08 DE DE19820599A patent/DE19820599A1/de not_active Withdrawn
-
1999
- 1999-05-07 DE DE59904632T patent/DE59904632D1/de not_active Expired - Lifetime
- 1999-05-07 AT AT99926300T patent/ATE234842T1/de not_active IP Right Cessation
- 1999-05-07 KR KR1020007012437A patent/KR20010052325A/ko not_active Ceased
- 1999-05-07 IL IL13948099A patent/IL139480A0/xx unknown
- 1999-05-07 AU AU43611/99A patent/AU754212B2/en not_active Ceased
- 1999-05-07 EP EP99926300A patent/EP1077980B1/de not_active Expired - Lifetime
- 1999-05-07 WO PCT/EP1999/003159 patent/WO1999058534A2/de not_active Ceased
- 1999-05-07 CA CA002330812A patent/CA2330812A1/en not_active Abandoned
- 1999-05-07 US US09/674,877 patent/US6982280B1/en not_active Expired - Fee Related
- 1999-05-07 HU HU0102283A patent/HUP0102283A3/hu unknown
- 1999-05-07 JP JP2000548338A patent/JP2002514649A/ja not_active Withdrawn
- 1999-05-07 ES ES99926300T patent/ES2195577T3/es not_active Expired - Lifetime
- 1999-05-10 AR ARP990102186A patent/AR018344A1/es not_active Application Discontinuation
- 1999-05-14 TW TW088107412A patent/TW568910B/zh not_active IP Right Cessation
-
2004
- 2004-02-17 US US10/780,181 patent/US20040259922A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002514649A5 (https=) | ||
| AU754212B2 (en) | Epothilone derivatives, a method for the production thereof, and their use | |
| NO992549D0 (no) | Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav | |
| JP2004502756A5 (https=) | ||
| DK1063228T5 (da) | Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| JP2005530811A5 (https=) | ||
| NO20045497L (no) | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater | |
| JP2004530689A5 (https=) | ||
| SU701537A3 (ru) | Способ получени нитрилов тиазол2-коричной кислоты | |
| JP2004526767A5 (https=) | ||
| JPH11158169A (ja) | 新規なクマリンのヒドロキシ及びポリヒドロキシ誘導体及びその製造方法 | |
| RU2004126861A (ru) | Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в) | |
| RU94031745A (ru) | Производные пиридобензоксадиазина, смесь их изомеров или отдельные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция с антибактериальной активностью | |
| JP2952493B2 (ja) | シクロペンタン誘導体 | |
| JP2005520805A5 (https=) | ||
| PE20030758A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion | |
| TH1404B (th) | อนุพันธ์ของอินโดลิซีนใหม่ และกรรมวิธีในการเตรียมอนุพันธ์นี้ | |
| ES8600188A1 (es) | Procedimiento de preparacion de un derivado 1,1-difenilpropan-1-ol | |
| JPS61186372A (ja) | ベンゾチアゾ−ルの製造方法 | |
| JPH0225472A (ja) | チアゾール誘導体及びその製造方法 | |
| JPH01313486A (ja) | β―アルコキシカルボニルエチル錫ジチオカ―バメート誘導体、その製造方法およびそれを含有する殺菌剤 | |
| JPS58162568A (ja) | 核置換ベンジル尿素誘導体およびその製造方法 | |
| TH808A (th) | อนุพันธ์ของอินโดลิซีนใหม่ และกรรมวิธีในการเตรียมอนุพันธ์นี้ | |
| JPS6256475A (ja) | ５−ハロピリジン−３−カルボキサミド化合物 | |
| HUP9902428A2 (hu) | Eljárás 2-(tiol-csoporttal helyettesített) 4-halogén-acetofenon-származékok előállítására |